Beaphar Worming Syrup, 9.4% W/V, Oral Solution
Revised: 08 June 2010
SUMMARY OF PRODUCT CHARACTERISTICS
1. Name of the Veterinary Medicinal Product
Beaphar Worming Syrup, 9.4% w/v, oral solution.
2. Qualitative and Quantitative Composition
Active substance % w/v
Piperazine Citrate 9.4
Methyl Parahydroxybenzoate 0.040% w/v
Ethyl Parahydroxybenzoate 0.010% w/v
Propyl Parahydroxybenzoate 0.005% w/v
Butyl Parahydroxybenzoate 0.015% w/v
For full list of excipients, see section 6.1
3. Pharmaceutical form
Bright reddish brown, clear solution.
4. Clinical Particulars
4.1 Target species
Dogs and cats.
4.2 Indications for use, specifying the target species
For the treatment of roundworms (Ascarids) in puppies and kittens.
Do not exceed stated dose.
Do not repeat treatment if vomiting occurs shortly after dosing.
4.4 Special warnings for each target species
Consult a veterinary surgeon before treating pregnant animals, or those with a history of epilepsy or severe renal disfunction.
4.5 Special precautions for use
i. Special precautions for use in animals
Do not exceed the recommended dosage.
ii. Special precautions to be taken by the person administering the medicinal product to animals
Following accidental skin or eye contact, wash the affected area with plenty of water. If irritation persists, seek medical advice.
Following accidental ingestion, drink plenty of water and seek medical attention.
Wash hands after use.
4.6 Adverse reactions (frequency and seriousness)
Overdosage (see section 4.10).
4.7 Use during pregnancy, lactation or lay
Consult a veterinary surgeon before treating pregnant animals.
Nursing female animals should be treated 2 weeks after giving birth and every two weeks at the same time as the puppies or kittens until weaning.
4.8 Interaction with other medicinal products and other forms of interaction
4.9 Amounts to be administered and administration route
For oral administration.
Administer directly into the corner of the mouth, or mixed with a little food. The rest of the meal should be offered afterwards to ensure all the syrup is taken.
Shake the bottle and prime dispenser before use by slowly depressing the plunger repeatedly, up to 5 times.
Animal Weight/kg Number of pumps
Up to 0.9 1 (1.1 ml)
0.91 - 1.8 2 (2.2 ml)
1.81 - 2.7 3 (3.3 ml)
2.71 - 3.6 4 (4.4 ml)
3.61 - 4.5 5 (5.5 ml)
4.51 - 5.4 6 (6.6 ml)
For every additional 0.9 kg bodyweight, an extra single pump volume should be administered.
Puppies and kittens should be treated for roundworms at 2 weeks of age.
They should be re-treated at 4, 6, 8, 10 and 12 weeks of age, and thereafter at 2 to 3 monthly intervals.
4.10 Overdose (symptoms, emergency procedures, antidotes) if necessary
Symptoms: Vomiting and diarrhoea, depression, ataxia, muscle weakness, and fits.
Emergency Procedures: Consult a veterinary surgeon.
Treat symptomatically and supportively.
Keep animal warm and calm.
Symptoms reverse in 24 - 48 hours.
4.11 Withdrawal period(s)
5. Pharmacological properties
5.1 Pharmacodynamic properties
Worms are killed in the gastro-intestinal tract and may be expelled in the faeces or digested in their passage through the tract.
5.2 Pharmacokinetic particulars
6. Pharmaceutical particulars
6.1 List of excipients
Sorbitol Solution 70% w/w (Non-Crystallising)
Imitation Chocolate Flavour 1470
6.3 Shelf life
Shelf life of the veterinary medicinal product as packaged for sale:3 years.
6.4 Special precautions for storage
Do not store above 25°C.
6.5 Nature and composition of immediate packaging
Size: 45 ml
Container: Round, amber Type III glass bottle.
Closure: White, tamper-evident polypropylene cap (screw fit) with low-density polyethylene liner.
Dosing device: Pump dispenser nominally delivering 1.1 ml per stroke
Use Orientation: Upright
6.6 Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
7. Marketing authorisation holder
Beaphar UK Ltd.
8. Marketing authorisation number
9. Date of first authorisation/renewal of the authorisation
Date of first authorisation: 21 September 1994
10. Date of revision of the text
Page 4 of 4